Proactiv MD ® Adapalene Gel 0.1% Acne Treatment

Manufacturer
Alchemee, LLC | G Production Inc
Effective date
2022-11-29
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 21:45:55

Label at a glance#

ProductProactiv MD Adapalene Acne Treatment
Active ingredientAdapalene
Label structure11 sections

Dosage and administration

Adults and children 12 years of age and older: use once daily clean the skin gently and pat dry before applying the product cover the entire affected area with a thin layer. For example, if your acne is on the face, apply the product to the entire face. do not use more than one time a day. Applying more than directed will not provide faster or better results, but may worsen skin irritation. Children under 12 years...

Storage and handling

store at room temperature 68°- 77°F protect from freezing

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Adapalene 0.1% (retinoid)1

1 read consumer information leaflet

Purpose

OTC - PURPOSE SECTION

Acne treatment

Use

INDICATIONS & USAGE SECTION

  • For the treatment of acne

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on damaged skin (cuts, abrasions, eczema, sunburn)
  • if you are allergic to adapalene or any of the ingredients in this product.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a doctor before use.

When using this product

OTC - WHEN USING SECTION

  • limit sun exposure, including light from tanning beds, and use sunscreen when going outdoors
  • do not wax to remove hair in areas where the product has been applied
  • during the early weeks of use, your acne may appear to worsen before it improves (this is normal); continue using as directed, unless you get irritation that becomes severe
  • irritation (redness, itching, dryness, burning) is more likely to occur:
    • in the first few weeks of use
    • if using more than one topical acne medication at a time
    • but irritation usually lessens with continued use of this product
  • it may take up to 3 months of once daily use to see results
  • avoid product contact with eyes, lips, and mouth. If contact occurs, immediately flush the area with water.
  • wash hands after use

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you become pregnant, or are planning to become pregnant, while using the product
  • you have symptoms of an allergic reaction (such as itching, rash, hives, swelling of the lips, eyelids, and shortness of breath)
  • irritation becomes severe
  • you see no improvement after 3 months of once daily use

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older:

  • use once daily
  • clean the skin gently and pat dry before applying the product
  • cover the entire affected area with a thin layer. For example, if your acne is on the face, apply the product to the entire face.
  • do not use more than one time a day. Applying more than directed will not provide faster or better results, but may worsen skin irritation.

Children under 12 years of age: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • store at room temperature 68°- 77°F
  • protect from freezing

Inactive ingredients

INACTIVE INGREDIENT SECTION

carbomer 940, edetate disodium, methylparaben, poloxamer 182, propylene glycol, purified water and sodium hydroxide. May contain hydrochloric acid to adjust pH.

Questions?

OTC - QUESTIONS SECTION

1-866-735-4137

SPL UNCLASSIFIED SECTION

Distributed by The Proactiv Company LLC
100 N Sepulveda Blvd., El Segundo, CA 90245

PRINCIPAL DISPLAY PANEL - 15 g Tube Box

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

proactiv MD®

ADAPALENE GEL 0.1%
ACNE TREATMENT

First FDA-Approved
Over-the-Counter
Topical Retinoid* for
Acne Treatment

Previously Available
Only By Prescription

Dermatologist
Developed and Tested

*Read carton and enclosed consumer
information leaflet before using
this product. Keep this carton and
consumer information leaflet.
They contain important information.

NET WT 0.5 OZ (15 g)

PRINCIPAL DISPLAY PANEL - 15 g Tube Box
PRINCIPAL DISPLAY PANEL - 15 g Tube Box

FDA-Initiated Inactive NDC Indexing#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11410-956PROACTIV MD ADAPALENE ACNE TREATMENT (ADAPALENE) GEL [ALCHEMEE, LLC]4Legacy NDC20221201_ab771c7e-ed01-442c-be0e-d368db6e4100.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11410-95611410-956-44, 11410-956-17, 11410-956-38

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020380-002DIFFERINADAPALENE0.1%GEL / TOPICALRLD, RS2016-07-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-0884e616aacf4f…
2026-08-18 06:07:402026-07N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-0831067a03dcf5…
2025-08-23 18:47 UTC2025-08N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-086a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-0803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-082680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-085bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-0879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-081e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-088072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-085c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-085d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-084b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-0874a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-0887673890dc5c…
2021-03-12 10:30 UTC2021-03N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-085aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-088869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-083f01610625f2…
2019-09-15 20:21 UTC2019-09N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08b00525d2431f…
2019-07-19 19:46 UTC2019-07N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-086a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-081c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-089b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-083f0d92c62455…
2023-05-13 08:27 UTC2023-05N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08053a50430f4f…
2023-01-26 05:58 UTC2023-01N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-083bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-083a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020380-002DIFFERIN0.1%GEL / TOPICALRLD, RS2016-07-08f41ea6bd6efb…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2019-12-13 00:20 UTC2019-12N020380-002RTO2019-07-0874a2ff9319b5…
2019-12-14 00:12 UTC2019-12N020380-002RTO2019-07-083f01610625f2…
2019-09-15 20:21 UTC2019-09N020380-002RTO2019-07-08b00525d2431f…
2019-07-19 19:46 UTC2019-07N020380-002RTO2019-07-08ea99ee380514…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
aa85d685-8498-4526-a9d2-a41eecc78030ab771c7e-ed01-442c-be0e-d368db6e41002025-03-31WarningsExact identifier
spl set id: ab771c7e-ed01-442c-be0e-d368db6e4100

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.